These findings are partially consistent with those reported in hereditary, BRCA1-associated breast cancer (BC), ERα-negative in ≈90% of cases [25] (reviewed by [26]), while BRCA2-mutated patients show a distribution of ER staining-like controls [25]. This evidence concerns the gene BRCA1 and breast cancer.